Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(3.47)
# 1,472
Out of 4,479 analysts
361
Total ratings
40.74%
Success rate
6.07%
Average return
Main Sectors:
36 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals | Reiterates: Buy | $60 | $45.81 | +30.98% | 18 | Jun 28, 2024 | |
| ARGX argenx SE | Maintains: Buy | $448 → $490 | $431.41 | +13.58% | 27 | Jun 26, 2024 | |
| MRNS Marinus Pharmaceuticals | Reiterates: Buy | $11 | $1.18 | +832.20% | 14 | Jun 18, 2024 | |
| PTGX Protagonist Therapeutics | Reiterates: Buy | $38 | $34.63 | +9.73% | 15 | Jun 14, 2024 | |
| CABA Cabaletta Bio | Reiterates: Buy | $30 | $7.50 | +300.00% | 17 | Jun 14, 2024 | |
| IRON Disc Medicine | Reiterates: Buy | $70 | $43.13 | +62.30% | 7 | Jun 14, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Neutral | $25 | $10.71 | +133.43% | 13 | Jun 12, 2024 | |
| ALKS Alkermes | Reiterates: Neutral | $35 | $24.18 | +44.75% | 11 | Jun 4, 2024 | |
| ROIV Roivant Sciences | Reiterates: Buy | $18 | $10.49 | +71.59% | 12 | May 31, 2024 | |
| BHVN Biohaven Pharmaceutical Holding Company | Reiterates: Buy | $59 | $34.12 | +72.92% | 8 | May 30, 2024 | |
| AEON AEON Biopharma | Reiterates: Buy | $6 | $1.01 | +494.06% | 5 | May 30, 2024 | |
| IMVT Immunovant | Reiterates: Buy | $51 | $26.45 | +92.82% | 15 | May 30, 2024 | |
| TBPH Theravance Biopharma | Reiterates: Buy | $20 | $8.41 | +137.81% | 9 | May 29, 2024 | |
| APLS Apellis Pharmaceuticals | Reiterates: Buy | $92 | $35.37 | +160.11% | 21 | May 28, 2024 | |
| CHRS Coherus BioSciences | Reiterates: Buy | $12 | $1.42 | +748.06% | 18 | May 24, 2024 | |
| EVO Evotec SE | Reiterates: Buy | $11 | $4.90 | +124.49% | 7 | May 23, 2024 | |
| RZLT Rezolute | Reiterates: Buy | $14 | $4.25 | +229.41% | 10 | May 22, 2024 | |
| EOLS Evolus | Reiterates: Buy | $27 | $10.74 | +151.40% | 14 | May 21, 2024 | |
| OTLK Outlook Therapeutics | Reiterates: Buy | $30 | $7.29 | +311.52% | 12 | May 17, 2024 | |
| TRVN Trevena | Maintains: Buy | $9 → $5 | $0.22 | +2,215.89% | 6 | May 16, 2024 | |
| DARE Daré Bioscience | Reiterates: Buy | $6 | $3.77 | +59.02% | 13 | May 15, 2024 | |
| SCPH scPharmaceuticals | Reiterates: Buy | $18 | $4.27 | +321.55% | 9 | May 15, 2024 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $105 | $39.66 | +164.75% | 16 | May 14, 2024 | |
| RVNC Revance Therapeutics | Maintains: Buy | $12 → $11 | $2.43 | +352.67% | 17 | May 13, 2024 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $37 → $27 | $12.25 | +120.41% | 9 | May 9, 2024 | |
| NERV Minerva Neurosciences | Maintains: Neutral | $11 → $7 | $3.15 | +122.22% | 8 | May 2, 2024 | |
| CERE Cerevel Therapeutics Holdings | Downgrades: Neutral | $41 → $45 | $41.16 | +9.34% | 6 | Dec 7, 2023 | |
| ELYM Eliem Therapeutics | Reiterates: Neutral | $6 | $6.66 | -9.84% | 3 | Mar 8, 2023 | |
| TXMD TherapeuticsMD | Downgrades: Neutral | $10 | $1.68 | +495.24% | 3 | Jun 7, 2022 | |
| HSTO Histogen | Maintains: Buy | $48 → $30 | $0.30 | +9,900.00% | 2 | Mar 29, 2022 | |
| RDUS Radius Health | Maintains: Neutral | n/a | $13.96 | - | 5 | Dec 9, 2021 | |
| DERM Journey Medical | Downgrades: Neutral | n/a | $5.17 | - | 1 | Jan 23, 2020 | |
| ICLR ICON PLC | Maintains: Equal-Weight | n/a | $317.14 | - | 3 | Mar 18, 2019 | |
| TEVA Teva Pharmaceutical | Maintains: Equal-Weight | n/a | $16.44 | - | 5 | Aug 6, 2018 | |
| PCRX Pacira BioSciences | Maintains: Overweight | n/a | $22.43 | - | 1 | Aug 6, 2018 | |
| PAHC Phibro Animal Health | Maintains: Underweight | n/a | $16.98 | - | 1 | Jul 5, 2018 |
Crinetics Pharmaceuticals
Jun 28, 2024
Reiterates: Buy
Price Target: $60
Current: $45.81
Upside: +30.98%
argenx SE
Jun 26, 2024
Maintains: Buy
Price Target: $448 → $490
Current: $431.41
Upside: +13.58%
Marinus Pharmaceuticals
Jun 18, 2024
Reiterates: Buy
Price Target: $11
Current: $1.18
Upside: +832.20%
Protagonist Therapeutics
Jun 14, 2024
Reiterates: Buy
Price Target: $38
Current: $34.63
Upside: +9.73%
Cabaletta Bio
Jun 14, 2024
Reiterates: Buy
Price Target: $30
Current: $7.50
Upside: +300.00%
Disc Medicine
Jun 14, 2024
Reiterates: Buy
Price Target: $70
Current: $43.13
Upside: +62.30%
Sage Therapeutics
Jun 12, 2024
Reiterates: Neutral
Price Target: $25
Current: $10.71
Upside: +133.43%
Alkermes
Jun 4, 2024
Reiterates: Neutral
Price Target: $35
Current: $24.18
Upside: +44.75%
Roivant Sciences
May 31, 2024
Reiterates: Buy
Price Target: $18
Current: $10.49
Upside: +71.59%
Biohaven Pharmaceutical Holding Company
May 30, 2024
Reiterates: Buy
Price Target: $59
Current: $34.12
Upside: +72.92%
AEON Biopharma
May 30, 2024
Reiterates: Buy
Price Target: $6
Current: $1.01
Upside: +494.06%
Immunovant
May 30, 2024
Reiterates: Buy
Price Target: $51
Current: $26.45
Upside: +92.82%
Theravance Biopharma
May 29, 2024
Reiterates: Buy
Price Target: $20
Current: $8.41
Upside: +137.81%
Apellis Pharmaceuticals
May 28, 2024
Reiterates: Buy
Price Target: $92
Current: $35.37
Upside: +160.11%
Coherus BioSciences
May 24, 2024
Reiterates: Buy
Price Target: $12
Current: $1.42
Upside: +748.06%
Evotec SE
May 23, 2024
Reiterates: Buy
Price Target: $11
Current: $4.90
Upside: +124.49%
Rezolute
May 22, 2024
Reiterates: Buy
Price Target: $14
Current: $4.25
Upside: +229.41%
Evolus
May 21, 2024
Reiterates: Buy
Price Target: $27
Current: $10.74
Upside: +151.40%
Outlook Therapeutics
May 17, 2024
Reiterates: Buy
Price Target: $30
Current: $7.29
Upside: +311.52%
Trevena
May 16, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $0.22
Upside: +2,215.89%
Daré Bioscience
May 15, 2024
Reiterates: Buy
Price Target: $6
Current: $3.77
Upside: +59.02%
scPharmaceuticals
May 15, 2024
Reiterates: Buy
Price Target: $18
Current: $4.27
Upside: +321.55%
Praxis Precision Medicines
May 14, 2024
Reiterates: Buy
Price Target: $105
Current: $39.66
Upside: +164.75%
Revance Therapeutics
May 13, 2024
Maintains: Buy
Price Target: $12 → $11
Current: $2.43
Upside: +352.67%
Viridian Therapeutics
May 9, 2024
Maintains: Buy
Price Target: $37 → $27
Current: $12.25
Upside: +120.41%
Minerva Neurosciences
May 2, 2024
Maintains: Neutral
Price Target: $11 → $7
Current: $3.15
Upside: +122.22%
Cerevel Therapeutics Holdings
Dec 7, 2023
Downgrades: Neutral
Price Target: $41 → $45
Current: $41.16
Upside: +9.34%
Eliem Therapeutics
Mar 8, 2023
Reiterates: Neutral
Price Target: $6
Current: $6.66
Upside: -9.84%
TherapeuticsMD
Jun 7, 2022
Downgrades: Neutral
Price Target: $10
Current: $1.68
Upside: +495.24%
Histogen
Mar 29, 2022
Maintains: Buy
Price Target: $48 → $30
Current: $0.30
Upside: +9,900.00%
Radius Health
Dec 9, 2021
Maintains: Neutral
Price Target: n/a
Current: $13.96
Upside: -
Journey Medical
Jan 23, 2020
Downgrades: Neutral
Price Target: n/a
Current: $5.17
Upside: -
ICON PLC
Mar 18, 2019
Maintains: Equal-Weight
Price Target: n/a
Current: $317.14
Upside: -
Teva Pharmaceutical
Aug 6, 2018
Maintains: Equal-Weight
Price Target: n/a
Current: $16.44
Upside: -
Pacira BioSciences
Aug 6, 2018
Maintains: Overweight
Price Target: n/a
Current: $22.43
Upside: -
Phibro Animal Health
Jul 5, 2018
Maintains: Underweight
Price Target: n/a
Current: $16.98
Upside: -